Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy

Journal of Clinical Microbiology

Volumn 50, Issue 10, 2012, Pages 3309-3317

  Sugui, Janyce A ^a   Peterson, Stephen W ^b   Clark, Lily P ^a   Nardone, Glenn ^c   Folio, Les ^c   Riedlinger, Gregory ^d   Zerbe, Christa S ^a   Shea, Yvonne ^c   Henderson, Christina M ^c   Zelazny, Adrian M ^c   Holland, Steven M ^a   Kwon Chung, Kyung J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR AGRICULTURAL UTILIZATION RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CASPOFUNGIN; GAMMA INTERFERON; ITRACONAZOLE; MICAFUNGIN; PENTAMIDINE; POSACONAZOLE; PYRROLE DERIVATIVE; TERBINAFINE; TUBERCULOSTATIC AGENT; VORICONAZOLE;

ACREMONIUM; ADD ON THERAPY; ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS; ASPERGILLUS TANNERI; AUTOPSY; BACTEREMIA; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DYSPNEA; EDEMA; FEVER; FUNGAL COLONIZATION; FUNGUS GROWTH; FUNGUS HYPHAE; FUSARIOSIS; HEMOPTYSIS; HEPATOMEGALY; HUMAN; HUMAN TISSUE; INVASIVE ASPERGILLOSIS; KLEBSIELLA; LIVER ABSCESS; LUNG ABSCESS; LUNG BIOPSY; LUNG LAVAGE; LUNG MYCOSIS; LYMPHADENOPATHY; MALE; MEDIASTINUM LYMPHADENOPATHY; MESENTERIC LYMPHADENOPATHY; MINIMUM INHIBITORY CONCENTRATION; MOLD PNEUMONIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOMYELITIS; PERIAORTIC LYMPHADENOPATHY; PHAEOACREMONIUM INFLATIPES; PLEURA EFFUSION; PNEUMONIA; PRESUMPTIVE TUBERCULOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEQUENCE ANALYSIS; SERRATIA MARCESCENS; SPLEEN ABSCESS; STAPHYLOCOCCUS AUREUS; TUBERCULOSIS; WEIGHT REDUCTION;

ADOLESCENT; AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CLUSTER ANALYSIS; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; ITRACONAZOLE; LUNG; MALE; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MOLECULAR SEQUENCE DATA; PHYLOGENY; PYRIMIDINES; SEQUENCE ANALYSIS, DNA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE; TRIAZOLES; YOUNG ADULT;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; MUS;

EID: 84866458499     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01509-12     Document Type: Article

References (42)

1. Aboul-Enein HY, Kutluk OB, Altiokka G, Tuncel M. 2002. A modified HPLC method for the determination of ochratoxin A by fluorescence detection. Biomed. Chromatogr. 16:470-474. (Pubitemid 35314925)
2. Balajee SA, et al. 2009. Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network. J. Clin. Microbiol. 47:3138-3141.
3. Bayman P, Baker JL, Doster MA, Michailides TJ, Mahoney NE. 2002. Ochratoxin production by the Aspergillus ochraceus group and Aspergillus alliaceus. Appl. Environ. Microbiol. 68:2326-2329. (Pubitemid 34477828)
4. Blumental S, et al. 2011. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin. Infect. Dis. 53:e159-e169.
5. Chenna R, et al. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31:3497-3500. (Pubitemid 37442184)
6. Christensen M. 1982. The Aspergillus ochraceus group: two new species from Western soils and a synoptic key. Mycologia 74:210-225.
7. Christensen M, Raper KB. 1978. Aspergillus robustus, a new species in the A. ochraceus group. Mycologia 70:200-205.
8. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard - 2nd ed (M38-A2). CLSI, Wayne, PA.
9. Cohen MS, et al. 1981. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am. J. Med. 71:59-66. (Pubitemid 12254714)
10. Dotis J, Roilides E. 2004. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int. J. Infect. Dis. 8:103-110. (Pubitemid 38166076)
11. Frisvad JC, Frank JM, Houbraken JAMP, Kuijpers AFA, Samson RA. 2004. New ochratoxin A producing species of Aspergillus section Circumdati. Stud. Mycol. 50:23-43.
12. Galagan JE, et al. 2005. Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature 438:1105-1115. (Pubitemid 41831674)
13. Gallin JI, Zarember K. 2007. Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease. Trans. Am. Clin. Climatol. Assoc. 118:175-185.
14. Geiser DM, Frisvad JC, Taylor JW. 1998. Evolutionary relationships in Aspergillus section Fumigati inferred from partial β-tubulin and hydrophobin DNA sequences. Mycologia 90:831-845. (Pubitemid 28490205)
15. Geiser DM, et al. 2007. The current status of species recognition and identification in Aspergillus. Stud. Mycol. 59:1-10. (Pubitemid 351155580)
16. Henry T, Iwen PC, Hinrichs SH. 2000. Identification of Aspergillus species using internal transcribed spacer regions 1 and 2. J. Clin. Microbiol. 38:1510-1515. (Pubitemid 30216681)
17. Hubka V, et al. 2012. Rare and new etiological agents revealed among 178 clinical Aspergillus strains obtained from Czech patients and characterized by molecular sequencing. Med. Mycol. 50:601-610.
18. Huelsenbeck JP, Ronquist F. 2001. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17:754-755. (Pubitemid 32851390)
19. Jurjevic Z, Peterson SW, Horn BW. 2012. Aspergillus section Versicolores: nine new species and multilocus DNA sequence based phylogeny. IMA Fungus 3:59-79.
20. Lionakis MS, et al. 2006. Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis. Antimicrob. Agents Chemother. 50:294-297. (Pubitemid 43042935)
21. Liu YJ, Whelen S, Hall BD. 1999. Phylogenetic relationships among ascomycetes: evidence from anRNApolymerse II subunit. Mol. Biol. Evol. 16:1799-1808.
22. Marino A, Nostro A, Fiorentino C. 2009. Ochratoxin A production by Aspergillus westerdijkiae in orange fruit and juice. Int. J. Food Microbiol. 132:185-189.
23. Mouy R, et al. 1994. Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J. Pediatr. 125:998-1003. (Pubitemid 24379140)
24. Page RD. 1996. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358.
25. Peterson SW. 2008. Phylogenetic analysis of Aspergillus species using DNA sequences from four loci. Mycologia 100:205-226.
26. Posada D, Crandall KA. 1998. MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817-818. (Pubitemid 28552116)
27. Rao GV, et al. 2003. Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J. Toxicol. Environ. Health A 66:1441-1452. (Pubitemid 36976208)
28. Ronquist F, Huelsenbeck JP. 2003. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19:1572-1574. (Pubitemid 37038874)
29. Schmitt I, et al. 2009. New primers for promising single-copy genes in fungal phylogenetics and systematics. Persoonia 23:35-40.
30. Segal BH, et al. 1998. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 77:345-354. (Pubitemid 28449835)
31. Segal BH, Romani L, Puccetti P. 2009. Chronic granulomatous disease. Cell Mol. Life Sci. 66:553-558.
32. Smith JE, Moss MO. 1985. Mycotoxins. Formation, analysis and significance. John Wiley & Sons, Chichester, England.
33. Sugui JA, et al. 2011. Identification and characterization of Aspergillus fumigatus "supermater" pair. mBio 2:e00234-11. doi:10.1128/mBio. 00234-11.
34. Sugui JA, et al. 2007. Role of laeA in the regulation of alb1, gliP, conidial morphology, and virulence in Aspergillus fumigatus. Eukaryot. Cell 6:1552-1561. (Pubitemid 47483598)
35. Varga J, Kevei E, Rinyu E, Teren J, Kozakiewicz Z. 1996. Ochratoxin production by Aspergillus species. Appl. Environ. Microbiol. 62:4461-4464. (Pubitemid 26399441)
36. Varga J, et al. 2000. Phylogenetic analysis of Aspergillus section Circumdati based on sequences of the internal transcribed spacer regions and the 5.8 S rRNA gene. Fungal Genet. Biol. 30:71-80. (Pubitemid 30666588)
37. Verweij PE, et al. 2008. Emericella quadrilineata as cause of invasive aspergillosis. Emerg. Infect. Dis. 14:566-572. (Pubitemid 351520857)
38. Vinh DC, et al. 2009. Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg. Infect. Dis. 15:1292-1294.
39. Vinh DC, et al. 2009. Invasive aspergillosis due to Neosartorya udagawae. Clin. Infect. Dis. 49:102-111.
40. Walsh TJ, et al. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46: 327-360. (Pubitemid 351265310)
41. White TJ, Bruns T, Lee S, Taylor JW. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, p 315-322. In Innis MA, Gelfand DH, Sninsky JJ, White TJ (ed), PCR protocols: a guide to methods and applications. Academic Press, Inc., New York, NY.
42. Winkelstein JA, et al. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169. (Pubitemid 30327530)